United States
Germany
Japan
United Kingdom
China
FGFR3 mouse monoclonal antibody, clone OTI1B10 (formerly 1B10)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
ERBB2 mouse monoclonal antibody, clone OTI4F10 (formerly 4F10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI6F8 (formerly 6F8)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 mouse monoclonal antibody,clone OTI4E1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAPK3 (ERK1) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
DAPK2 (DAP Kinase 2 ) mouse monoclonal antibody, clone OTI1C5 (formerly 1C5)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 mouse monoclonal antibody,clone OTI4E1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
ERBB2 mouse monoclonal antibody, clone OTI4F10 (formerly 4F10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI6F8 (formerly 6F8)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
ARAF mouse monoclonal antibody, clone OTI2G4 (formerly 2G4)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
MAPK3 (ERK1) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
FGFR3 mouse monoclonal antibody, clone OTI1G10 (formerly 1G10)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
